Cargando…
Limbic network co‐localization predicts pharmacoresistance in dysplasia‐related epilepsy
To evaluate the role of focal cortical dysplasia co‐localization to cortical functional networks in the development of pharmacoresistance. One hundred thirty‐six focal cortical dysplasia patients with 3.0 T or 1.5 T MRI were identified from clinical databases at Children's National Hospital. Cl...
Autores principales: | Cohen, Nathan T., Chang, Phat, Gholipour, Taha, Oluigbo, Chima, Vezina, L. Gilbert, Xie, Hua, Zhang, Anqing, Gaillard, William D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646997/ https://www.ncbi.nlm.nih.gov/pubmed/37700505 http://dx.doi.org/10.1002/acn3.51892 |
Ejemplares similares
-
Pharmacoresistant Abdominal Seizures in Symptomatic Localization-Related Epilepsy
por: Tushar, Vadakke Puthanveetil, et al.
Publicado: (2021) -
Cortical stimulation in pharmacoresistant focal epilepsies
por: Ellrich, Jens
Publicado: (2020) -
Genetic variations associated with pharmacoresistant epilepsy
por: Cárdenas-Rodríguez, Noemí, et al.
Publicado: (2020) -
Vagal nerve stimulation for pharmacoresistant epilepsy in children
por: Hauptman, Jason S., et al.
Publicado: (2012) -
Improving Therapy of Pharmacoresistant Epilepsies: The Role of Fenfluramine
por: Dini, Gianluca, et al.
Publicado: (2022)